Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development

Human organoids are small, self-organized, three-dimensional (3D) tissue cultures that have started to revolutionize medical science in terms of understanding disease, testing pharmacologically active compounds, and offering novel ways to treat disease. Organoids of the liver, kidney, intestine, lun...

Full description

Bibliographic Details
Main Author: Parisa Gazerani
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/4/3113
_version_ 1797620588707053568
author Parisa Gazerani
author_facet Parisa Gazerani
author_sort Parisa Gazerani
collection DOAJ
description Human organoids are small, self-organized, three-dimensional (3D) tissue cultures that have started to revolutionize medical science in terms of understanding disease, testing pharmacologically active compounds, and offering novel ways to treat disease. Organoids of the liver, kidney, intestine, lung, and brain have been developed in recent years. Human brain organoids are used for understanding pathogenesis and investigating therapeutic options for neurodevelopmental, neuropsychiatric, neurodegenerative, and neurological disorders. Theoretically, several brain disorders can be modeled with the aid of human brain organoids, and hence the potential exists for understanding migraine pathogenesis and its treatment with the aid of brain organoids. Migraine is considered a brain disorder with neurological and non-neurological abnormalities and symptoms. Both genetic and environmental factors play essential roles in migraine pathogenesis and its clinical manifestations. Several types of migraines are classified, for example, migraines with and without aura, and human brain organoids can be developed from patients with these types of migraines to study genetic factors (e.g., channelopathy in calcium channels) and environmental stressors (e.g., chemical and mechanical). In these models, drug candidates for therapeutic purposes can also be tested. Here, the potential and limitations of human brain organoids for studying migraine pathogenesis and its treatment are communicated to generate motivation and stimulate curiosity for further research. This must, however, be considered alongside the complexity of the concept of brain organoids and the neuroethical aspects of the topic. Interested researchers are invited to join the network for protocol development and testing the hypothesis presented here.
first_indexed 2024-03-11T08:43:44Z
format Article
id doaj.art-31ef8bc77f1d42a0981bdb4bef8b7310
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T08:43:44Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-31ef8bc77f1d42a0981bdb4bef8b73102023-11-16T20:55:23ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01244311310.3390/ijms24043113Human Brain Organoids in Migraine Research: Pathogenesis and Drug DevelopmentParisa Gazerani0Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, 0130 Oslo, NorwayHuman organoids are small, self-organized, three-dimensional (3D) tissue cultures that have started to revolutionize medical science in terms of understanding disease, testing pharmacologically active compounds, and offering novel ways to treat disease. Organoids of the liver, kidney, intestine, lung, and brain have been developed in recent years. Human brain organoids are used for understanding pathogenesis and investigating therapeutic options for neurodevelopmental, neuropsychiatric, neurodegenerative, and neurological disorders. Theoretically, several brain disorders can be modeled with the aid of human brain organoids, and hence the potential exists for understanding migraine pathogenesis and its treatment with the aid of brain organoids. Migraine is considered a brain disorder with neurological and non-neurological abnormalities and symptoms. Both genetic and environmental factors play essential roles in migraine pathogenesis and its clinical manifestations. Several types of migraines are classified, for example, migraines with and without aura, and human brain organoids can be developed from patients with these types of migraines to study genetic factors (e.g., channelopathy in calcium channels) and environmental stressors (e.g., chemical and mechanical). In these models, drug candidates for therapeutic purposes can also be tested. Here, the potential and limitations of human brain organoids for studying migraine pathogenesis and its treatment are communicated to generate motivation and stimulate curiosity for further research. This must, however, be considered alongside the complexity of the concept of brain organoids and the neuroethical aspects of the topic. Interested researchers are invited to join the network for protocol development and testing the hypothesis presented here.https://www.mdpi.com/1422-0067/24/4/3113migraineheadachebrainorganoidsbrain organoidhuman brain organoids
spellingShingle Parisa Gazerani
Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
International Journal of Molecular Sciences
migraine
headache
brain
organoids
brain organoid
human brain organoids
title Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
title_full Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
title_fullStr Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
title_full_unstemmed Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
title_short Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development
title_sort human brain organoids in migraine research pathogenesis and drug development
topic migraine
headache
brain
organoids
brain organoid
human brain organoids
url https://www.mdpi.com/1422-0067/24/4/3113
work_keys_str_mv AT parisagazerani humanbrainorganoidsinmigraineresearchpathogenesisanddrugdevelopment